Soleno Therapeutics, Inc. (SLNO) has been on a downward spiral lately with significant selling pressure. After declining 21.7 ...

Soleno Therapeutics ( ($SLNO) ) has issued an announcement. During August 18-19, 2025, Soleno Therapeutics‘ senior management participated in a ...

Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face ...

Soleno Therapeutics Inc (NASDAQ:SLNO) stock fell 13% Friday morning following a short report from Scorpion Capital that raised serious concerns about the company’s recently approved Prader-Willi ...

Recent health news highlights Britain's decision not to support the bioethanol industry, Berkshire Hathaway's investment in ...

Scorpion Capital disclosed a short position in Soleno Therapeutics on Friday, citing issues with the drugmaker's recently approved treatment Vykat XR, sending its shares slumping 15% in premarket ...

The UK's bioethanol industry faces collapse due to the trade deal with Trump, leaving the government opting not to intervene.

Shares of Soleno Therapeutics, Inc. (SLNO) have gained 1% over the past four weeks to close the last trading session at ...

Analysts are estimating that Soleno Therapeutics will report an earnings per share (EPS) of $-0.53. The market awaits Soleno ...

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key ...

REDWOOD CITY, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the ...

REDWOOD CITY, Calif., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the ...